½ÃÀ庸°í¼­
»óǰÄÚµå
1790336

ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Á¦Ç° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2033³â)

North America Contrast Media Injectors Market Size, Share & Trends Analysis By Product (Injector Systems, Consumables), By Type, By Application (Radiology, Interventional Cardiology), By End-use, By Region, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 110 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå °³¿ä

ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð´Â 2024³â¿¡ 8¾ï 936¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2033³â¿¡´Â 18¾ï 2,890¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2033³â CAGRÀº 9.69%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠼ö¿ä´Â MRI, CT ½ºÄµ, Ç÷°üÁ¶¿µ¼ú°ú °°Àº ¿µ»ó °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÁÖ»ç±â ¾ø´Â ÁÖÀÔ±â¿Í °°Àº ÷´Ü ±â¼úÀÇ Ã¤ÅÃÀÌ È®´ëµÊ¿¡ µû¶ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹Ì±¹°ú ij³ª´ÙÀÇ ÀÇ·á ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. Canadian Medical Imaging Inventory(CMII) º¸°í¼­¿¡ µû¸£¸é ij³ª´Ù¿¡¼­´Â 2022-2023³â ¾à 6,385,665°ÇÀÇ CT °Ë»ç°¡ ½Ç½ÃµÇ¾úÀ¸¸ç, Àα¸ 1,000¸í´ç Æò±Õ 160.2°ÇÀÇ °Ë»ç°¡ ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ´ë·®ÀÇ ¿µ»ó °Ë»ç·Î ÀÎÇØ ÇâÈÄ ¼ö³â°£ Á¶¿µÁ¦ ÁÖÀÔ ÀåÄ¡ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶ÇÇÑ ¾Ï, ½ÉÀ庴 µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ºÏ¹Ì Á¶¿µÁ¦ ÁÖÀԱ⠻ê¾÷ÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ì±¹ ±¹¸³ÀÇÇеµ¼­°ü¿¡ µû¸£¸é 2025³â 5¿ù ¹Ì±¹ °ÅÁÖ ¼ºÀÎÀÇ CAD À¯º´·üÀº 2022³â±îÁö 3³â µ¿¾È 4.6%¿¡¼­ 4.9%·Î Áõ°¡ÇÏ¿© ÷´Ü ½ÉÇ÷°ü ¿µ»ó ÃÔ¿µÀÌ ÇÊ¿äÇÑ È¯ÀÚ Àα¸°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.

¸¶Âù°¡Áö·Î ij³ª´ÙÀÇ ¾Ï ¹ßº´·üµµ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Canadian Medical Association JournalÀÌ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é ij³ª´Ù¿¡¼­´Â 2024³â ¾à 247,100¸íÀÇ ½Å±Ô ¾Ï ȯÀÚ°¡ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ ºÎ´ã Áõ°¡·Î ÀÎÇØ CT ½ºÄµÀ̳ª MRI¿Í °°Àº Á¤¹ÐÇϰí È¿À²ÀûÀÎ ¿µ»ó Áø´Ü ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ±â¼úÀº ¿µ»óÀÇ ¼±¸íµµ¸¦ ³ôÀ̱â À§ÇØ Á¶¿µÁ¦ ÁÖÀÔ ÀåÄ¡¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ºÏ¹ÌÀÇ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº Áø´Ü Á¤È®µµ¿Í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ Çõ½ÅÀûÀÎ Á¶¿µÁ¦ ÁÖÀÔ ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ºÐ¼® Åø
    • »ê¾÷ ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå Á¦Ç° º¯µ¿ ºÐ¼®
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(Á¦Ç°º°, 2021-2033³â)
  • ÁÖÀԱ⠽ýºÅÛ
  • ¼Ò¸ðǰ

Á¦5Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå : À¯Çüº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå À¯Çü º¯µ¿ ºÐ¼®
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(À¯Çüº°, 2021-2033³â)
  • ½Ì±Û Çìµå ÁÖÀÔ±â
  • µà¾ó Çìµå ÁÖÀÔ±â
  • ½Ã¸°Áö¸®½º ÁÖÀÔ±â

Á¦6Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ¿ëµµ º¯µ¿ ºÐ¼®
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(¿ëµµº°, 2021-2033³â)
  • ¹æ»ç¼±°ú
  • IC(Interventional Cardiology)
  • ÀÎÅͺ¥¼Ç ¿µ»óÀÇÇÐ

Á¦7Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀÔ±â : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(ÃÖÁ¾ ¿ëµµº°, 2021-2033³â)
  • º´¿ø
    • ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2021-2033³â
  • Áø´Ü ¼¾ÅÍ
    • ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2021-2033³â
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2021-2033³â

Á¦8Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2021-2033³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦9Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀï ºÐ·ù
    • À̳뺣ÀÌÅÍ
  • º¥´õ ±¸µµ
    • ÁÖ¿ä ÆÇ¸Å ´ë¸®Á¡°ú ä³Î ÆÄÆ®³Ê ¸®½ºÆ®
    • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
    • Bracco Diagnostics Inc.
    • Shenzhen Boon Medical Supply Co., Ltd.
    • Bayer Corporation
    • Guerbet LLC
    • B. Braun Medical Inc.
    • ulrich GmbH & Co. KG
    • Shenzhen Antmed Co., Ltd.
    • Ecomed Solutions
    • Siemens Medical Solutions USA, Inc
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • 2024³â ±â¾÷ ½ÃÀå Á¡À¯À² ¿¹Ãø ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷ ¸®½ºÆ®
KSA 25.08.26

North America Contrast Media Injectors Market Summary

The North America contrast media injectors market size was estimated at USD 809.36 million in 2024 and is projected to reach USD 1,828.90 million by 2033, growing at a CAGR of 9.69% from 2025 to 2033. The demand for contrast media injectors in North America is increasing due to the rising need for imaging tests such as MRI, CT scans, and angiography, along with the growing adoption of advanced technologies like syringeless injectors.

The growing demand for medical imaging in the U.S. and Canada is driving market growth. Data from the Canadian Medical Imaging Inventory (CMII) report indicates that approximately 6,385,665 CT exams were conducted, averaging 160.2 exams per 1,000 people in Canada in 2022-2023. This high volume of imaging procedures is expected to increase the demand for contrast media injectors in the coming years.

Furthermore, the increasing prevalence of chronic diseases such as cancer and heart disease is expected to significantly drive the growth of the North America contrast media injectors industry. According to the National Library of Medicine, in May 2025, the prevalence of CAD among adults living in the U.S. rose from 4.6% to 4.9% within 3 years till 2022, indicating a growing patient population requiring advanced cardiovascular imaging.

Similarly, cancer incidence in Canada is significantly increasing. According to data published by the Canadian Medical Association Journal, approximately 247,100 new cancer cases are projected for Canada in 2024. This rising disease burden is increasing the demand for precise and efficient diagnostic imaging techniques such as CT scans and MRIs, which rely heavily on contrast media injectors to enhance image clarity. As a result, healthcare providers across North America are investing in innovative contrast injector systems to improve diagnostic accuracy and patient outcomes, fueling market expansion.

North America Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America contrast media injectors market report based on product, type, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Injector systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Syringes
    • Tubings
    • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-head injectors
  • Dual head injectors
  • Syringeless injectors
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiology
  • Interventional cardiology
  • Interventional radiology
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostics centers
  • Ambulatory surgery centers
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for imaging tests
      • 3.2.1.2. Rising launches and approvals of contrast media injectors
      • 3.2.1.3. Increasing prevalence of chronic disorders
      • 3.2.1.4. Growing adoption of syringeless injectors
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Potential complications and risks associated with contrast media injections
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Rising number of distribution agreements
      • 3.2.3.2. Advancements in contrast media injectors
      • 3.2.3.3. Growing clinical trials for contrast media and injectors
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of radiologists and healthcare professionals
  • 3.3. North America Contrast Media Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. North America Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Contrast Media Injectors Market Product Movement Analysis
  • 4.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Injector systems
    • 4.4.1. Injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.1. CT injector systems
        • 4.4.1.1.1. CT injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2. MRI injector systems
        • 4.4.1.2.1. MRI injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.3. Cardiovascular/angiography injector systems
        • 4.4.1.3.1. Cardiovascular/angiography injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.1. Syringes
        • 4.5.1.1.1. Syringes market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.2. Tubings
        • 4.5.1.2.1. Tubings market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. North America Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Contrast Media Injectors Market Type Movement Analysis
  • 5.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single head injectors
    • 5.4.1. Single head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Dual head injectors
    • 5.5.1. Dual head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Syringeless injectors
    • 5.6.1. Syringeless injectors market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. North America Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America Contrast Media Injectors Market Application Movement Analysis
  • 6.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Radiology
    • 6.4.1. Radiology market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.5. Interventional cardiology
    • 6.5.1. Interventional cardiology market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.6. Interventional radiology
    • 6.6.1. Interventional radiology market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. North America Contrast Media Injectors Devices: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America Contrast Media Injectors Market End Use Movement Analysis
  • 7.3. North America Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.5. Diagnostics centers
    • 7.5.1. Diagnostics centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. North America Contrast Media Injectors Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Bracco Diagnostics Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Shenzhen Boon Medical Supply Co., Ltd.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Bayer Corporation
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Guerbet LLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. B. Braun Medical Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. ulrich GmbH & Co. KG,
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Shenzhen Antmed Co., Ltd.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Ecomed Solutions
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Siemens Medical Solutions USA, Inc
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
  • 9.4. Heat Map Analysis/ Company Market Position Analysis
  • 9.5. Estimated Company Market Share Analysis, 2024
  • 9.6. List of Other Key Market Players
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦